Skip to main content
NIH funding notice RFA-AA-21-004

SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)

Closed on August 17, 2021.

Posted
February 5, 2021
Close date
August 17, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $427,971 in first-year total cost, median $213,986.

Most frequent study sections

  1. Special Emphasis Panel[ZAA1 DD (05)]2

Most frequent institutions

  1. LSU HEALTH SCIENCES CENTER1
  2. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
Competing awards under RFA-AA-21-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Interaction of Biopsychosocial Stress, Alcohol Misuse, and Neurobehavioral Sequelae of COVID-191R21AA030206-01EDWARDS, SCOTTFERGUSON, TEKEDA F.LSU HEALTH SCIENCES CENTER, LA$220,500ZAA1
2022The impact of the COVID-19 pandemic on adolescent drinking in a longitudinal cohort spanning 21 U.S. cities1R21AA030197-01PELHAM III, WILLIAM ELLERBEUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$207,471ZAA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AA-21-004: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience